GoAI
Get started
FALCO HOLDINGS Co., Ltd. logo

FALCO HOLDINGS Co., Ltd.

4671.T

JPXHealthcareMedical - Diagnostics & Research

Open in GoAI

Latest quote

¥2,848

+¥24.00 · +0.85%

Aug 24, 11:30 AM JST

4671.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

FALCO HOLDINGS Co., Ltd., a medical services enterprise established in 1962 and headquartered in Kyoto, Japan, primarily delivers clinical diagnostic testing and pharmaceutical dispensing solutions. The company serves medical institutions and various corporations throughout Japan. Its comprehensive range of clinical testing encompasses specialized areas such as genetics, biochemistry, hematology, pathology, immunology, microbiology, and radioimmunoassay. Beyond direct diagnostics, FALCO HOLDINGS also engages in genomic-based drug discovery and the development of biotechnological pharmaceuticals. The company's offerings extend to medical information technology services, as well as environmental and food sanitation testing. They also provide genetic testing tailored for the food industry, catering to manufacturers, retailers, and restaurants. Additionally, FALCO HOLDINGS operates dispensing pharmacies and drugstores. They are also active in the development and sale of medical information systems, notably including "@home Dr.," an electronic medical record system designed for clinics with a high volume of clinical testing, and "TASCAL for ASP," a robust medical support system.

Industry
Medical - Diagnostics & Research
Sector
Healthcare
Headquarters
JP
CEO
Tadashi Yasuda
Listed since
Oct 29, 2004
Employees
1,037

Market position

Day range

Current ¥2,848

52-week range

Current ¥2,848

Open
¥2,824
Previous close
¥2,824
Volume
5.9K
0.44× average
Average volume
13.43K
Average daily volume
Market cap
28.51B JPY
Beta
0.27
Market reference 1
50-day average
¥2,662.2
+6.98% above average
200-day average
¥2,626.86
+8.42% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
18.16B JPY
P/E (TTM)
13.69×
P/B (TTM)
1.12×
P/S (TTM)
0.65×
EV / EBITDA
5.1×
Earnings yield
7.70%
Free cash flow yield
5.87%
Dividend yield
4.39%

Profitability & efficiency

Gross margin
31.90%
Operating margin
5.93%
Net margin
4.77%
Return on equity
7.79%
Return on assets
5.47%
Return on invested capital
5.52%

Financial health

Debt / equity
0.04×
Current ratio
2.37×
Altman Z-score
3.93
Piotroski F-score
6 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends38%25%13%1%Gross margin, FY2021: 34.64%Gross margin, FY2022: 31.22%Gross margin, FY2023: 30.05%Gross margin, FY2024: 30.83%Gross margin, FY2025: 31.69%Operating margin, FY2021: 10.99%Operating margin, FY2022: 6.55%Operating margin, FY2023: 5.00%Operating margin, FY2024: 5.39%Operating margin, FY2025: 5.73%Net margin, FY2021: 7.07%Net margin, FY2022: 4.82%Net margin, FY2023: 3.87%Net margin, FY2024: 4.43%Net margin, FY2025: 4.63%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 34.64%. Gross margin FY2022 31.22%. Gross margin FY2023 30.05%. Gross margin FY2024 30.83%. Gross margin FY2025 31.69%. Operating margin FY2021 10.99%. Operating margin FY2022 6.55%. Operating margin FY2023 5.00%. Operating margin FY2024 5.39%. Operating margin FY2025 5.73%. Net margin FY2021 7.07%. Net margin FY2022 4.82%. Net margin FY2023 3.87%. Net margin FY2024 4.43%. Net margin FY2025 4.63%.

Income trends

Revenue

43.58B JPY+0.61%

Operating income

2.5B JPY+7.02%

Net income

2.02B JPY+5.00%
Income trends across reported periods54.84B JPY35.5B JPY16.17B JPY−3.17B JPYRevenue, FY2021: 50.01B JPYRevenue, FY2022: 46.91B JPYRevenue, FY2023: 43.01B JPYRevenue, FY2024: 43.31B JPYRevenue, FY2025: 43.58B JPYOperating income, FY2021: 5.5B JPYOperating income, FY2022: 3.08B JPYOperating income, FY2023: 2.15B JPYOperating income, FY2024: 2.34B JPYOperating income, FY2025: 2.5B JPYNet income, FY2021: 3.53B JPYNet income, FY2022: 2.26B JPYNet income, FY2023: 1.67B JPYNet income, FY2024: 1.92B JPYNet income, FY2025: 2.02B JPYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 50.01B JPY. Revenue FY2022 46.91B JPY. Revenue FY2023 43.01B JPY. Revenue FY2024 43.31B JPY. Revenue FY2025 43.58B JPY. Operating income FY2021 5.5B JPY. Operating income FY2022 3.08B JPY. Operating income FY2023 2.15B JPY. Operating income FY2024 2.34B JPY. Operating income FY2025 2.5B JPY. Net income FY2021 3.53B JPY. Net income FY2022 2.26B JPY. Net income FY2023 1.67B JPY. Net income FY2024 1.92B JPY. Net income FY2025 2.02B JPY.
Metric (JPY)FY2025FY2024FY2023FY2022FY2021
Revenue43.58B JPY43.31B JPY43.01B JPY46.91B JPY50.01B JPY
Cost of goods sold29.77B JPY29.96B JPY30.08B JPY32.27B JPY32.68B JPY
Gross profit13.81B JPY13.35B JPY12.92B JPY14.64B JPY17.32B JPY
Research and development————300M JPY
Selling, general, and administrative11.31B JPY11.02B JPY9.34B JPY10.13B JPY10.31B JPY
Operating expenses11.31B JPY11.02B JPY10.77B JPY11.57B JPY11.83B JPY
Interest income11M JPY1M JPY———
Interest expense5M JPY5M JPY8M JPY19M JPY27M JPY
Depreciation and amortization1.06B JPY941M JPY978M JPY1.04B JPY958M JPY
Operating income2.5B JPY2.34B JPY2.15B JPY3.08B JPY5.5B JPY
Net income2.02B JPY1.92B JPY1.67B JPY2.26B JPY3.53B JPY

Company facts updated Aug 24, 2026.

Earnings

Latest fiscal-year EPS
200.01
FY2025 · +10.62% year over year
Latest fiscal-year revenue
43.58B JPY
FY2025 · +0.61% year over year

Annual EPS trend

Reported history and fiscal-year consensus

ReportedConsensus forecast
Annual EPS trend355.53281.09206.64132.2FY21FY22FY23FY24FY25

Annual revenue trend

Reported history and fiscal-year consensus

ReportedConsensus forecast
Annual revenue trend50.71B47.91B45.11B42.31BFY21FY22FY23FY24FY25

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

¥125.5

2025 complete year+116.4% since 2021

2026 partial: ¥62.50

* Partial calendar year in the available dividend history.

Corporate action history

DividendUpcoming

Ex-dividend Sep 29, 2026

¥64.00

Semi-Annual

Record Sep 30, 2026 · Payment Sep 29, 2026

DividendUpcoming

Ex-dividend Mar 31, 2027

¥64.00

Semi-Annual

Record Mar 31, 2027 · Payment Mar 31, 2027

Dividend

Ex-dividend Mar 30, 2026

¥62.50

Semi-Annual

Record Mar 31, 2026 · Payment Jun 26, 2026

Dividend

Ex-dividend Sep 29, 2025

¥62.50

Semi-Annual

Record Sep 30, 2025 · Payment Dec 1, 2025

Dividend

Ex-dividend Mar 28, 2025

¥63.00

Semi-Annual

Record Mar 31, 2025 · Payment Jun 25, 2025

Dividend

Ex-dividend Sep 27, 2024

¥60.00

Annual

Record Sep 30, 2024 · Payment Dec 2, 2024

4671.T peers

Chugai Pharmaceutical Co., Ltd. logo

4519.T

Chugai Pharmaceutical Co., Ltd.

¥7,008

-0.04%

Takeda Pharmaceutical Company Limited logo

4502.T

Takeda Pharmaceutical Company Limited

¥5,799

+0.61%

HOYA Corporation logo

7741.T

HOYA Corporation

¥24,990

+0.38%

Otsuka Holdings Co., Ltd. logo

4578.T

Otsuka Holdings Co., Ltd.

¥12,205

+0.08%

Daiichi Sankyo Company, Limited logo

4568.T

Daiichi Sankyo Company, Limited

¥2,862

+1.01%

Astellas Pharma Inc. logo

4503.T

Astellas Pharma Inc.

¥2,392.5

+0.23%

ETFs holding 4671.T

Funds reporting this stock among their holdings, ordered by reported position size.

iShares Core TOPIX ETF logoiShares Core TOPIX ETF1475.T
Market value
49.7M
Weight
0.00%
AUM
2.89T JPY
Expense ratio
0.05%
Price / 1D
¥418.5+0.12%
WisdomTree Japan SmallCap Dividend Fund logoWisdomTree Japan SmallCap Dividend FundDFJ
Market value
200.57K
Weight
0.05%
AUM
388.69M USD
Expense ratio
0.58%
Price / 1D
$113.06+0.82%
Dimensional - International Small Cap ETF logoDimensional - International Small Cap ETFDFIS
Market value
128.38K
Weight
0.00%
AUM
5.91B USD
Expense ratio
0.39%
Price / 1D
$37.545+0.71%
Dimensional - International Core Equity 2 ETF logoDimensional - International Core Equity 2 ETFDFIC
Market value
124.81K
Weight
0.00%
AUM
15.43B USD
Expense ratio
0.22%
Price / 1D
$39.405+0.83%
Dimensional World ex U.S. Core Equity 2 ETF logoDimensional World ex U.S. Core Equity 2 ETFDFAX
Market value
110.55K
Weight
0.00%
AUM
12.57B USD
Expense ratio
0.28%
Price / 1D
$38.16+0.82%
WisdomTree International Equity Fund logoWisdomTree International Equity FundDWM
Market value
58.23K
Weight
0.01%
AUM
686.84M USD
Expense ratio
0.48%
Price / 1D
$76.67+0.85%
Avantis International Small Cap Equity ETF logoAvantis International Small Cap Equity ETFAVDS
Market value
3.55K
Weight
—
AUM
340.61M USD
Expense ratio
0.30%
Price / 1D
$80.49+0.93%

Continue in GoAI

Research 4671.T

research.disclaimer